0001203311-23-000016.txt : 20230221 0001203311-23-000016.hdr.sgml : 20230221 20230221193335 ACCESSION NUMBER: 0001203311-23-000016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230216 FILED AS OF DATE: 20230221 DATE AS OF CHANGE: 20230221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LIU JEAN I CENTRAL INDEX KEY: 0001241357 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 23650110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seagen Inc. CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA DATE OF NAME CHANGE: 20001116 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2023-02-16 0 0001060736 Seagen Inc. SGEN 0001241357 LIU JEAN I 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 Chief Legal Officer Common Stock 2023-02-16 4 M 0 5000 39.15 A 90113 D Common Stock 2023-02-16 4 S 0 5000 155.0 D 85113 D Non-Qualified Stock Option (right to buy) 39.15 2023-02-16 4 M 0 5000 0.0 D 2025-08-25 Common Stock 5000 17446 D Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Options vested at a rate of 25% on 8/25/2016 and monthly thereafter until all the options were fully vested on 8/25/19. By: /s/ Jennifer Prosba For: Jean I Liu 2023-02-21